Overview
- 4 inspections across 4 sites are on record.
- 16 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-10.
At a glance
Inspections
4
Sites
4
Observations
16
Career since
May 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| AstraZeneca AB | 10 Apr 2026 | Human Drugs | On file |
| Medical Products Laboratories, Inc. | 13 Mar 2020 | Human Drugs | View 483 → |
| Alfasigma SpA | 30 Jun 2017 | Human Drugs | On file |
| ALK-Abello, Inc. | 18 May 2012 | On file |
Sites inspected
AstraZeneca ABSodertalje, Sweden1 insp.
Medical Products Laboratories, Inc.Philadelphia, United States1 insp.
Alfasigma SpAPomezia, Italy1 insp.
ALK-Abello, Inc.Plainville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Rowena S Nguyen1 shared
Rachael O Oyewole1 shared
Christina K Theodorou1 shared
Lauren N Smith1 shared
Lauren N Howard1 shared
Ramon E Martinez1 shared
Robert J Martin1 shared
Full investigator report
Get the verbatim findings behind Allison A Aldridge's 16 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site